Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Use of Nuclear Medicine Technology for Clinical Molecular Imaging: a Message from the Associate Editor

Use of Nuclear Medicine Technology for Clinical Molecular Imaging: a Message from the Associate... Nucl Med Mol Imaging (2016) 50:183–184 DOI 10.1007/s13139-016-0413-1 ISSN (print) 1869-3482 EDITORIAL ISSN (online) 1869-3474 Use of Nuclear Medicine Technology for Clinical Molecular Imaging: a Message from the Associate Editor Byeong-Cheol Ahn Received: 14 March 2016 /Accepted: 28 March 2016 /Published online: 11 April 2016 Korean Society of Nuclear Medicine 2016 Molecular imaging is defined as the visual representation, majority of tumors utilize glucose more actively than characterization, and quantification of biological processes at normal tissues. High avidity of radioiodine in thyroid the cellular and subcellular levels within intact living organ- follicular cells functions as the tracer for thyroid dis- isms; this can be achieved by various imaging technologies eases, while high glucose avidity of tumor functions as F-18 FDG for oncologic disorders. The elucidation of such as nuclear imaging, optical imaging, magnetic resonance imaging (MRI), ultrasound imaging, and computed tomogra- pathophysiology of certain diseases lead to the develop- phy (CT) [1]. Although these modalities are actively used for ment of new diagnostic tracers, which in turn shed more sensing molecular and cellular processes in preclinical studies, light on the disease pathophysiology. This virtuous cy- the majority of imaging techniques remain unapplied in the cle would aid in uncovering http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Nuclear Medicine and Molecular Imaging Springer Journals

Use of Nuclear Medicine Technology for Clinical Molecular Imaging: a Message from the Associate Editor

Loading next page...
 
/lp/springer-journals/use-of-nuclear-medicine-technology-for-clinical-molecular-imaging-a-zdK7F7RjZ4

References (5)

Publisher
Springer Journals
Copyright
Copyright © 2016 by Korean Society of Nuclear Medicine
Subject
Medicine & Public Health; Nuclear Medicine; Imaging / Radiology; Orthopedics; Cardiology; Oncology
ISSN
1869-3474
eISSN
1869-3482
DOI
10.1007/s13139-016-0413-1
pmid
27540421
Publisher site
See Article on Publisher Site

Abstract

Nucl Med Mol Imaging (2016) 50:183–184 DOI 10.1007/s13139-016-0413-1 ISSN (print) 1869-3482 EDITORIAL ISSN (online) 1869-3474 Use of Nuclear Medicine Technology for Clinical Molecular Imaging: a Message from the Associate Editor Byeong-Cheol Ahn Received: 14 March 2016 /Accepted: 28 March 2016 /Published online: 11 April 2016 Korean Society of Nuclear Medicine 2016 Molecular imaging is defined as the visual representation, majority of tumors utilize glucose more actively than characterization, and quantification of biological processes at normal tissues. High avidity of radioiodine in thyroid the cellular and subcellular levels within intact living organ- follicular cells functions as the tracer for thyroid dis- isms; this can be achieved by various imaging technologies eases, while high glucose avidity of tumor functions as F-18 FDG for oncologic disorders. The elucidation of such as nuclear imaging, optical imaging, magnetic resonance imaging (MRI), ultrasound imaging, and computed tomogra- pathophysiology of certain diseases lead to the develop- phy (CT) [1]. Although these modalities are actively used for ment of new diagnostic tracers, which in turn shed more sensing molecular and cellular processes in preclinical studies, light on the disease pathophysiology. This virtuous cy- the majority of imaging techniques remain unapplied in the cle would aid in uncovering

Journal

Nuclear Medicine and Molecular ImagingSpringer Journals

Published: Apr 11, 2016

There are no references for this article.